ARCPOINT REPORTS Q1 2025 FINANCIAL RESULTS

Core Viewpoint - ARCpoint Inc. has reported its unaudited Q1 2025 financial results, highlighting a significant decrease in revenues and a net loss reduction compared to the previous year, primarily due to cost management strategies and the impact of the CRESSO transaction [1][12]. Financial Performance - Total revenues for Q1 2025 were $0.18 million, a decrease from $1.61 million in Q1 2024, attributed to the absence of royalty and franchising revenues following the CRESSO joint venture [12]. - The net loss for Q1 2025 was $0.62 million, improved from a net loss of $1.5 million in Q1 2024, driven by reduced costs in various operational areas [12]. - Operating cash flow for Q1 2025 was negative $0.9 million, an improvement from negative $1.3 million in Q1 2024 [12]. - EBITDA for Q1 2025 was negative $0.4 million, compared to negative $1.2 million in Q1 2024, indicating improved operational performance [12]. - Adjusted EBITDA for Q1 2025 was negative $0.6 million, compared to negative $1.0 million in Q1 2024, reflecting a similar trend of reduced losses [12]. Cost Management - The company has implemented temporary reductions in overall compensation and professional services costs amounting to approximately $57,000 per month, representing about 40% of total monthly compensation and recurring professional services costs [2][3]. - These cost reductions are part of the company's strategy to manage finances while focusing on increasing revenues through the MyARCpointLabs (MAPL) technology platform [2][3]. CRESSO Transaction - The CRESSO transaction, completed on August 20, 2024, involved a joint venture with Any Lab Test Now, creating the largest franchise network of its kind in the U.S. [4]. - Following the CRESSO transaction, ARCpoint holds a 29.5% interest in CRESSO, which is now accounted for using the equity method, leading to the deconsolidation of ARCpoint's franchise operations from its financial statements [4][5]. Cash Position - As of March 31, 2025, the company had total cash on hand of approximately $0.23 million, following the sale of its 68% share in ABH Greenville for $360,000 [6].